Back to Agendas
Codevelopment of a Drug in the Pharmaceutical Industry: Is It Ever Fun?
Session Chair(s)
Jayanthi Reddy, MBA, MS
Eikon Therapeutics, Head of Project and Portfolio Management, United States
A culture of collaboration with external partners is one of the key drivers of future success. This forum will focus on the challenges and barriers in codevelopment and the business models being adopted to ensure a healthy collaboration.
Learning Objective : Discuss a generic business model being adopted by pharmaceutical and biotechnology organizations for codevelopment of a drug; Describe the variations from the generic business model for successful codevelopment of a drug; Explain how the alliance manager and project manager can work together to make the collaboration fun and exciting.
Speaker(s)
Panelist
Douglas E Wilson, PharmD
Alliance Director, GlaxoSmithKline, United States
Panelist
Karla D'Alessio, PMP
Executive Director, Merck & Co., Inc., United States
Panelist
Elizabeth Somers, MS
Associate Vice President, Global Project and Alliance Management, Merck & Co., Inc., United States
Have an account?
Ways to register
Registration override should work.